PTC
OREX

Private Trust Company’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Private Trust Company’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10
Closed – – 1759
2014
Q3 		$0 Hold
10
– – ﹤0.01% 2095
2014
Q2 		$1K Hold
10
– – ﹤0.01% 1918
2014
Q1 		$1K Sell
10
-3
-23% -$203 ﹤0.01% 1797
2013
Q4 		$1K Hold
13
– – ﹤0.01% 1748
2013
Q3 		$1K Hold
13
– – ﹤0.01% 1696
2013
Q2 		$1K Buy
+13
New +$800 ﹤0.01% 1659

Other funds holding OREX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Private Trust Company's OREX Position: Q4 2014 in Review

Private Trust Company sold out of Orexigen Therapeutics, Inc. (OREX) in Q4 2014, closing a stake of 10 shares.

Private Trust Company first reported a position in OREX in Q2 2013 and held it in 6 quarters. The position peaked at $1K in Q2 2014. 147 funds tracked by Wall St. Rank hold OREX as of Q4 2014.

  • Private Trust Company reported no remaining Orexigen Therapeutics, Inc. position as of Q4 2014 after selling out during the quarter.
  • Private Trust Company sold 10 Orexigen Therapeutics, Inc. shares in Q4 2014.
  • Private Trust Company first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 6 quarters.
  • Private Trust Company's Orexigen Therapeutics, Inc. position peaked at $1K in Q2 2014.
  • 147 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q4 2014.

Based on Private Trust Company's 13F filing for Q4 2014, filed 28 Jan 2015.